Skip to content

Kevin Cameron

Director at AdvanCell.

Earliest Form D on file: Jul 2026

Filed Jul 16, 2026

AdvanCell

Lead-212 alpha therapies for prostate and other cancers

Biotech, Cambridge MA

Named, Director.

$218.3M

sold of $315M offered

Form D

Network

At AdvanCell

10 people

4 more at AdvanCell